Cisen Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Cisen Pharmaceutical Co Ltd cash flow reinvestment rate. Cisen Pharmaceutical Co Ltd (603367) has a Cash Flow Reinvestment Rate of 0.08x as of September 2025, reinvesting CN¥25.75 Million (capex CN¥25.75 Million ) from operating cash flow of CN¥311.93 Million. Explore 603367 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Cisen Pharmaceutical Co Ltd (2011–2025)
Cash flow reinvestment rate of Cisen Pharmaceutical Co Ltd from 2011 to 2025. Historical reinvestment intensity for Cisen Pharmaceutical Co Ltd across 15 annual periods. Explore 603367 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Cisen Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2011–2025)
Cisen Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2011 to 2025. Year-by-year capital reinvestment analysis for Cisen Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Cisen Pharmaceutical Co Ltd cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.47x | CN¥217.88 Million | CN¥466.37 Million | CN¥64.76 Million | ▲ +68.0% |
| 2024 | 0.28x | CN¥158.78 Million | CN¥570.85 Million | CN¥101.81 Million | ▲ +94.7% |
| 2023 | 0.14x | CN¥64.48 Million | CN¥451.24 Million | CN¥17.71 Million | ▼ -88.1% |
| 2022 | 1.20x | CN¥309.32 Million | CN¥258.35 Million | CN¥35.19 Million | ▼ -18.0% |
| 2021 | 1.46x | CN¥341.01 Million | CN¥233.60 Million | CN¥51.02 Million | ▲ +119.8% |
| 2020 | 0.66x | CN¥286.30 Million | CN¥431.01 Million | CN¥202.27 Million | ▼ -47.5% |
| 2019 | 1.27x | CN¥229.41 Million | CN¥181.26 Million | CN¥103.37 Million | ▼ -62.5% |
| 2018 | 3.38x | CN¥1.37 Billion | CN¥406.68 Million | CN¥40.36 Million | ▲ +319.1% |
| 2017 | 0.81x | CN¥354.18 Million | CN¥439.61 Million | CN¥23.98 Million | ▲ +129.6% |
| 2016 | 0.35x | CN¥102.45 Million | CN¥291.97 Million | CN¥42.45 Million | ▲ +389.5% |
| 2015 | 0.07x | CN¥19.09 Million | CN¥266.24 Million | CN¥19.09 Million | ▼ -95.9% |
| 2014 | 1.77x | CN¥48.68 Million | CN¥27.54 Million | CN¥48.68 Million | ▼ -36.1% |
| 2013 | 2.77x | CN¥224.88 Million | CN¥81.26 Million | CN¥224.88 Million | ▲ +217.4% |
| 2012 | 0.87x | CN¥28.85 Million | CN¥33.09 Million | CN¥28.85 Million | ▼ -49.1% |
| 2011 | 1.71x | CN¥130.58 Million | CN¥76.28 Million | CN¥130.58 Million | — |